Involvement of wild-type p53 in radiation-induced c-jun N-terminal kinase activation in human thyroid cells

Anticancer Research

Volumn 21, Issue 4 A, 2001, Pages 2569-2575

  Shklyaev, S S ^a   Namba, H ^a   Sautin, Y ^a   Mitsutake, N ^a   Nagayama, Y ^a   Ishikawa, N ^a   Ito, K ^a   Zeki, K ^a   Yamashita, S ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Ceramide; Ionizing radiation; JNK; P53

Indexed keywords

CERAMIDE; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CANCER CELL CULTURE; CELL FATE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IONIZING RADIATION; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; RADIOSENSITIVITY; THYROID CANCER; THYROID CELL;

CELLS, CULTURED; CERAMIDES; DIGLYCERIDES; ENZYME ACTIVATION; GENES, P53; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; SPHINGOSINE; THYROID GLAND; THYROID NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035155166     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Sounding the alarm: Protein kinase cascades activated by stress and inflammation
2. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain
3. Jun-NH2-terminal kinase activation mediated by UV-induced DNA lesions in melanoma and fibroblast cells
4. The c-Jun N-terminal kinase pathway and apoptotic signaling (review)
5. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis
6. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain
7. JNK targets p 53 ubiquitination and degradation in nonstressed cells
8. Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways
9. Mitogen-activated protein kinase kinase 2 activation is essential for progression through the G2/M checkpoint arrest in cells exposed to ionizing radiation
10. MEKK1/JNK signaling stabilizes and activates p 53
11. JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases
12. p21WAF1 is dynamically associated with JNK in human T-lymphocytes during cell cycle progression
13. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases
14. p53 mediates bcl-2 phosphorylation and apoptosis via activation of the Cdc42/JNK 1 pathway
15. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc 42Hs
16. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway
17. Interleukin-1 production and action in thyroid tissue
18. Reexpression of thyroid peroxidase in a derivative of an undifferentiated thyroid carcinoma cell line by introduction of wild-type p 53
19. p53 induced by ionizing radiation mediates DNA end-jointing activity, but not apoptosis of thyroid cells
20. Ceramide-induced apoptosis of human thyroid cancer cells resistant to apoptosis by irradiation
21. Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells
22. Nagataki S and Yamashita S: Radiation-induced G1 arrest is selectively mediated by the p53- WAF1/Cipl pathway in human thyroid cells
23. Ionizing radiation activates c-Jun NH2-terminal kinase (JNK/SAPK) via a PKC-dependent pathway in human thyroid cells
24. Ceramide activates the stress-activated protein kinases
25. p53-dependent ceramide response to genotoxic stress
26. Signal transduction and cellular radiation responses
27. Radiation carcinogenesis
28. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation
29. Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation
30. Activation of the JNK pathway is essential for transformation by the Met oncogene
31. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas
32. Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2- terminal protein kinases (JNKS): Evidence for a divergence of the ERKs and JNKs pathways induced by Ret
33. High prevalence of mutations of the p53 gene in poorly human thyroid carcinomas
34. Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner
35. Mutational status of the p53 gene modulates the basal level of jun N- terminal kinase and its inducibility by ultraviolet irradiation in A1- 5 rat fibroblasts